Winter 2015/2016 - The Innovation Highway Newsletter | Page 9

2 1 DECEMBER 2015 – JANUARY 2016 2015 GEW Medical Finalists (con’d) InfraSonic Monitoring, Vestal, USA InfraSonic Monitoring is a technology capable of providing non-invasive, continuous assessment of cardiac output suitable for consumer use. What once was available only in hospital or research settings will be available to the entire community. Symptify – Symptoms Simplified, USA Symptify is an online self-assessment tool that uses a customized algorithmic engine to help users educate themselves about causes of symptoms. Tourniquet of Instant Gas Release, Tel Aviv, Uri Hadelsberg is a 29 year old senior year medical student, who has an interest in neurosurgery, innovation and aeronautics. I am passionate about new innovations which can benefit the fields of neurosurgery and medicine in particular and humanity in general! MediCounsel – Providing Hope, Mumbai, India MediCounsel is a functioning, user-friendly, healthcare consulting portal designed to assist the treatment of patients suffering from complex, rare and hopeless medical conditions. The Tourniquet of Instant Gas Release is a tourniquet system, which eliminates the MGM Bio, Copenhagen, Denmark human factor to guarantee successful use in MGM Bio is a business-to-business biotechnology company that provides a novel any situation. The exact and equal pressure approach to drug discovery. It delivers natural, applied throughout the tourniquet makes this a small molecules targeting viral diseases to the game changer in first aid situations whether it is being used in civilian scenarios or by pharmaceutical industry. MGM Bio soldiers in combat service. We are currently technology is cheaper, faster and generates looking for investors in TIGR Tech and its more chemical diversity than established unique tourniquet. methods such as combinatorial chemical libraries and virtual molecule screening. MGM Bio wins Venture Cup Life Science and Med Tech 2014. Novus Life Sciences Limited, Hong Kong NOVUS is a biotech startup. NOVUS’s major focus is the development of orthobiologics. This includes the research and development of a series of biomaterial filler formulations for minimal invasive surgery. The profitability is promising as the potential market of orthobiologics is enormous and it is still growing around the globe. email: [email protected] 6